Factors associated with uncontrolled asthma in Porto Alegre, Brazil

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 11, 2009, Pages 1097-1103

  Dalcin, P T R ^a   Menegotto, D M ^a   Zanonato, A ^a   Franciscatto, L ^b   Soliman, F ^a   Figueiredo, M ^a   Pereira, R P ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Associated factors; Control level; Disease control; Prevalence; Treatment and control

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; XANTHINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRAZIL; CHILD; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HEALTH CARE ACCESS; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE;

EID: 71049160050     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009005000035     Document Type: Article

References (23)

1. Schatz M, Zeiger RS, Vollmer WM, Mosen D, Cook EF. Determinants of future long-term asthma control. J Allergy Clin Immunol 2006; 118: 1048-1053. (Pubitemid 44666992)
2. National Heart Lung and Blood Institute. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Bethesda: National Institute of Health. National Heart, Lung and Blood Institute publication No. 02-3659; 2006.
3. Soriano JB, Rabe KF, Vermeire PA. Predictors of poor asthma control in European adults. J Asthma 2003; 40: 803-813.
4. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004; 170: 836-844. (Pubitemid 39346477)
5. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007; 120: 1360-1367. (Pubitemid 350225685)
6. Chipps BE, Spahn JD. What are the determinates of asthma control? J Asthma 2006; 43: 567-572.
7. de Vries MP, van den Bemt L, Lince S, Muris JW, Thoonen BP, van Schayck CP. Factors associated with asthma control. J Asthma 2005; 42: 659-665.
8. Herjavecz I, Nagy GB, Gyurkovits K, Magyar P, Dobos K, Nagy L, et al. Cost, morbidity, and control of asthma in Hungary: The Hunair Study. J Asthma 2003; 40: 673-681. (Pubitemid 37296155)
9. National Heart Lung and Blood Institute. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Bethesda: National Institute of Health. National Heart, Lung and Blood Institute publication No. 02-3659; 2002.
10. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976; 113: 587-600.
11. Gregg I, Nunn AJ. Peak expiratory flow in normal subjects. Br Med J 1973; 3: 282-284.
12. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 2007; 119: 1454-1461. (Pubitemid 46863372)
13. [IV Brazilian Guidelines for the management of asthma]. J Bras Pneumol 2006; 32 (Suppl 7): S447-S474.
14. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120 (5; Suppl): S94-S138.
15. British Guideline on the Management of Asthma. Thorax 2008; 63 (Suppl 4): iv1-121.
16. Barnes PJ. The size of the problem of managing asthma. Respir Med 2004; 98 (Suppl B): S4-S8.
17. Prieto LO, Badiola C, Villa JR, Plaza V, Molina J, Cimas E. Asthma control: do patients' and physicians' opinions fit in with patients' asthma control status? J Asthma 2007; 44: 461-467. (Pubitemid 47123754)
18. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000; 117: 542-550. (Pubitemid 30111609)
19. Ganderton D. General factors influencing drug delivery to the lung. Respir Med 1997; 91 (Suppl A): 13-16. (Pubitemid 27453645)
20. Gayrard P, Orehek J. [Inadequate use of pressurized aerosols by asthmatic patients [author's transl]. Respiration 1980; 40: 47-52.
21. Horsley MG, Bailie GR. Risk factors for inadequate use of pressurized aerosol inhalers. J Clin Pharm Ther 1988; 13: 139-143.
22. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396-402.
23. Claudio L, Tulton L, Doucette J, Landrigan PJ. Socioeconomic factors and asthma hospitalization rates in New York City. J Asthma 1999; 36: 343-350. (Pubitemid 29318974)